Home › Research › How common it is
Psoriasis and dementia: A population‐based matched cohort study of adults in England
Julian Matthewman, Kathryn Elizabeth Mansfield, Sharon Louise Cadogan, Katrina Abuabara, Catherine Smith, Krishnan Bhaskaran, Sinéad Langan, Charlotte Warren‐Gash. Annals of Clinical and Translational Neurology, 2025-01-01
Topic: Risk, prevention and care in population studies
Among 360,014 individuals with psoriasis and 1,799,617 without, psoriasis was associated with a small increased risk of all-cause dementia (adjusted hazard ratio [aHR] 1.06, 95% CI 1.04-1.08; absolute rate difference 24 per 100,000 person-years). Strength of association increased with time since psoriasis diagnosis (e.g. aHR 0.99, 0.96-1.03 within 0 to 5 years; 1.20, 1.05-1.37 within 20 to 25 years). The association was stronger for vascular dementia (aHR 1.10, 1.06-1.14) than Alzheimer's dementia (aHR 1.03, 1.00-1.06). Hazard ratios were larger for severe psoriasis (all-cause aHR 1.32, 1.25-1.39; vascular aHR 1.58, 1.44-1.74; Alzheimer's aHR 1.11, 1.02-1.21). Long-term risk of all-cause dementia and vascular dementia, but not Alzheimer's dementia, was slightly higher in people with psoriasis, but absolute risk differences were small. Risks were more substantially raised with time since psoriasis diagnosis and in severe psoriasis compared to mild to moderate psoriasis, suggesting a potential dose-response relationship.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Matthewman, J., Mansfield, K. E., Cadogan, S. L., Abuabara, K., Smith, C., Bhaskaran, K., et al. (2025). Psoriasis and dementia: A population‐based matched cohort study of adults in England. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.52283
Vancouver
Matthewman J, Mansfield KE, Cadogan SL, Abuabara K, Smith C, Bhaskaran K, et al. Psoriasis and dementia: A population‐based matched cohort study of adults in England. Annals of Clinical and Translational Neurology. 2025. doi:10.1002/acn3.52283. PMID: 39743756.
BibTeX
@article{matthewman2025-39743756,
author = {Matthewman, Julian and Mansfield, Kathryn Elizabeth and Cadogan, Sharon Louise and Abuabara, Katrina and Smith, Catherine and Bhaskaran, Krishnan and Langan, Sinéad and Warren‐Gash, Charlotte},
title = {{Psoriasis and dementia: A population‐based matched cohort study of adults in England}},
journal = {Annals of Clinical and Translational Neurology},
year = {2025},
doi = {10.1002/acn3.52283},
pmid = {39743756},
url = {https://doi.org/10.1002/acn3.52283}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 8 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- Among 360,014 individuals with psoriasis and 1,799,617 without, psoriasis was associated with a small increased risk of all-cause dementia (adjusted hazard ratio [aHR] 1.06, 95% CI 1.04-1.08; absolute rate difference 24 per 100,000 person-years).
- Strength of association increased with time since psoriasis diagnosis (e.g. aHR 0.99, 0.96-1.03 within 0 to 5 years; 1.20, 1.05-1.37 within 20 to 25 years).
- The association was stronger for vascular dementia (aHR 1.10, 1.06-1.14) than Alzheimer's dementia (aHR 1.03, 1.00-1.06).
- Hazard ratios were larger for severe psoriasis (all-cause aHR 1.32, 1.25-1.39; vascular aHR 1.58, 1.44-1.74; Alzheimer's aHR 1.11, 1.02-1.21).
- Long-term risk of all-cause dementia and vascular dementia, but not Alzheimer's dementia, was slightly higher in people with psoriasis, but absolute risk differences were small.
Why it matters
People with psoriasis had a small increased risk of all-cause and vascular dementia, with larger risks in severe psoriasis and longer time since diagnosis, but absolute risk differences were small. This kind of study cannot show that psoriasis causes dementia and tests no treatment or prevention.
New to this subject? Start with our plain-English guide: Alzheimer's in numbers →
Study details
- Participants360,014
- Effect sizeaHR 0.99; aHR 1.10; aHR 1.03
- Evidence strengthModerate
How this study scored 50/100
Published in a peer-reviewed journal. Scored zero for study design and randomised / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Annals of Clinical and Translational Neurology) |
| Journal's citation record | 1 / 4 | Annals of Clinical and Translational Neurology: journal h-index 97 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 4 / 4 | 360,014 participants |
| Effect reported | 3 / 3 | Effect reported with a statistic (interval, p-value, ratio or similar) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomised / blinded | 0 / 2 | No randomisation or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 3 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 1.0 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 2 / 6 | Cited 1.9× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 3 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Charlotte Warren‐Gash: h-index 33 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | University of California, San Francisco: institution h-index 1,915 (OpenAlex) |
| Multi-centre collaboration | 2 / 3 | OpenAlex lists 4 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 39743756) |
| Free to read | 2 / 2 | Free to read |
| Total | 50 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1002/acn3.52283
- PubMed: 39743756
- Original source →
- Free full text: Annals of Clinical and Translational Neurology →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related studies in How common it is
Also tagged “prevalence”
1,224 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,224 tagged studies.